Background and Purpose-This study aimed to determine, among older men, the risk and independent significant baseline prognostic factors for first-ever stroke and MI. Methods-We performed a prospective cohort study of 4382 community-dwelling older men (mean age, 75.4Ϯ4.2 years) with no history of stroke or MI. Baseline data comprised questionnaire responses, clinical measurements, and comorbidity. Results-After a median of 6 years (interquartile range, 5.2-7.2) of follow-up, the overall rate of stroke/MI was 2.61 (95% CI, 2.42-2.81) per 100 person-years. Among major traditional risk prediction variables, only age and smoking were significantly associated with stroke/MI. In our final multivariate model, the independent significant predictors of stroke/MI were age (HR for age older than 85, 3.18; 95% CI, 2.05-4.93), diastolic blood pressure Ͻ70 Key Words: aging Ⅲ myocardial infarction Ⅲ risk factors Ⅲ stroke A ge and the traditional vascular risk factors are major contributors to lifetime risk of vascular events and mortality. 1 The effectiveness of lifestyle changes (such as smoking cessation), antiplatelet therapy, and the control of hypertension, dyslipidemia, and diabetes in the prevention of vascular events is established. 2 These interventions are now the cornerstone of medical prevention of vascular diseases and have led to a decline in the incidence of stroke/MI in high-income countries. 3 Despite these improvements, population aging will be associated with increased prevalence of vascular disease, presenting a need to further understand and ameliorate risk factors for cardiovascular events among older people. Commonly used cardiovascular risk charts are based on the Framingham risk equation, which was derived from individuals aged 30 to 74 years. 4 Few older people have been included in observational studies and randomized trials of the effect of interventions to reduce vascular events. 5 In addition, the association between individual traditional risk factors and cardiovascular risk appears to diminish among older people, 6,7 and current risk prediction tools may not be applicable to this population. 8 Assessment of nontraditional risk factors is not currently recommended for screening for coronary heart disease risk, although the need for further research is recognized. 9 We undertook a prognostic study of community-based older men who were free of stroke and MI at baseline to: (1i) examine the performance of current risk prediction tools; (2) Received September 23, 2010; accepted October 26, 2010 
A ge and the traditional vascular risk factors are major contributors to lifetime risk of vascular events and mortality. 1 The effectiveness of lifestyle changes (such as smoking cessation), antiplatelet therapy, and the control of hypertension, dyslipidemia, and diabetes in the prevention of vascular events is established. 2 These interventions are now the cornerstone of medical prevention of vascular diseases and have led to a decline in the incidence of stroke/MI in high-income countries. 3 Despite these improvements, population aging will be associated with increased prevalence of vascular disease, presenting a need to further understand and ameliorate risk factors for cardiovascular events among older people. Commonly used cardiovascular risk charts are based on the Framingham risk equation, which was derived from individuals aged 30 to 74 years. 4 Few older people have been included in observational studies and randomized trials of the effect of interventions to reduce vascular events. 5 In addition, the association between individual traditional risk factors and cardiovascular risk appears to diminish among older people, 6, 7 and current risk prediction tools may not be applicable to this population. 8 Assessment of nontraditional risk factors is not currently recommended for screening for coronary heart disease risk, although the need for further research is recognized. 9 We undertook a prognostic study of community-based older men who were free of stroke and MI at baseline to: (1i) examine the performance of current risk prediction tools; (2) determine the lifestyle and clinical factors that may influence risk of incident stroke and MI among community-dwelling older men; and (3) determine participants' future risks of fatal and nonfatal stroke and MI.
Methodology Study Design
The Health in Men Study (HIMS) is a prospective cohort study.
Setting
HIMS recruited community-dwelling older men in Perth, Western Australia. Of 19 352 men randomly selected from the electoral roll and invited to participate, 12 203 (63%) men aged between 65 and 83 years attended for screening in the Western Australian randomized controlled trial of screening for abdominal aortic aneurysms between April 1996 and January 1999. 10 Between 2001 and 2004, 10 940 surviving members of this cohort were invited to complete a risk factor survey and a face-to-face clinical review. 11 
Participants
Five thousand five hundred eighty-three men completed the risk factor survey. We excluded participants (nϭ1201) with a history of stroke (nϭ330), MI (nϭ746), or both (nϭ125) before baseline using a search of all available inpatient and outpatient diagnosis fields recorded in the Western Australian Data Linkage System dating back to 1988. The Western Australian Data Linkage System is a comprehensive population-based linkage system that connects together up to 40 years of data for Ͼ30 collections for residents of Western Australia. 12 All diagnostic fields were included to ascertain a history of stroke/MI among participants not admitted for the actual event. Participants were thus 4382 older men who enrolled in HIMS and were free from a history of stroke/MI at baseline, of who 3382 consented to donate a blood sample.
Baseline Measures: Clinical Features
Participants were invited to undergo physical examination, provide an early morning blood sample, and complete a brief cognitive assessment. Girth at hips and waist (in centimeters) and blood pressure were measured using standard procedures. Blood samples were collected between 0800 and 1030 hours, and assays were performed on the day of collection. Assays were performed in the Biochemistry Department, PathWest, Royal Perth Hospital, Western Australia, to determine glucose, homocysteine, lipids, creatinine, triglyceride, high-density and low-density lipoprotein, and highsensitivity C-reactive protein (CRP) concentrations.
Creatinine and fasting serum glucose, total and high-density lipoprotein cholesterol, and triglycerides were assayed using a Roche Hitachi 917 analyzer (Roche Diagnostic GmbH). The coefficients of variation for creatinine were 6.6% at 70.5 mol/L and 4.1% at 484 mol/L; for glucose, coefficients of variation were 2.9% at 4.8 mmol/L and 2.2% at 15.2 mmol/L; for cholesterol, coefficients of variation were 2.3% at 3.2 mmol/L and 2.1% at 6.7 mmol/L; for high-density lipoprotein, coefficients of variation were 2.4% at 0.8 mmol/L and 2.5% at 1.7 mmol/L; and for triglycerides, coefficients of variation were 4.8% at 0.9 mmol/L and 2.4% at 2.0 mmol/L. CRP was measured using particle-enhanced immunonephelometry using a Dade Behring BNII analyzer (Dade Behring Marburg GmbH). Between-day imprecision was 8.0% at 0.36 mg/L, 4.5% at 4.13 mg/L, 5.2% at 13.5 mg/L, and 3.2% at 51.3 mg/L. Homocysteine concentrations were determined using competitive immunoassay (Immulite 2000; Diagnostic Products). The coefficient of variation was 7.3% at 12.4 mol/L and 7.0% at 34.6 mol/L. Creatinine and age were used to calculate an estimate of glomerular filtration rate using the Modification of Diet in Renal Disease study formula. 13 Cognitive function was assessed with the standardized MiniMental State Examination, a structured version of the original Folstein Mini-Mental State Examination. 14 Smoking history, included in the questionnaire, was categorized into smoker (current or past) and nonsmoker. Western Australian Data Linkage System inpatient data were used to assign a baseline comorbidity profile to each participant. This was based on the Charlson Index, 15 which was applied to the 10-year period before baseline. The Charlson Index identifies 17 common medical conditions: myocardial infarction, congestive heart failure, peripheral arterial disease, cerebrovascular disease, dementia, chronic pulmonary disease, connective tissue disease, ulcer disease, liver disease, diabetes (including diabetes with end-organ damage), hemiplegia, renal disease, leukemia, lymphoma, other tumors, metastatic tumors, and AIDS.
Follow-Up and Outcome Events
Patients were followed-up by means of the Western Australian Data Linkage System between the date of HIMS recruitment (2001) (2002) (2003) (2004) and October 15, 2009 (or death if sooner). The primary outcome of the study was incident stroke/MI, defined as a stroke (fatal and nonfatal) or MI (fatal and nonfatal), and was collected using the Western Australian Data Linkage System. Incident stroke/MI during follow-up was identified by searching all available diagnosis fields (to ascertain a history of stroke/MI among participants not admitted for the actual stroke/MI event 
Statistical Analysis
Data were analyzed using the statistical software package Stata (version 11, StataCorp). We used Cox proportional hazards regression modeling to examine the association of vascular risk factors with incident stroke/MI. This commenced with a series of univariate models to identify all candidate predictor variables. Continuous variables were evaluated as such and, when possible, as categories to increase the potential clinical utility of any final risk model. CRP concentration was Ͼ3.0 mg/L Ϫ1 and was considered elevated. 16 Hyperhomocysteinemia was defined as a homocysteine concentration of Ն15 umol/L Ϫ1 . 17 Diastolic blood pressure was categorized at 70 mm Hg based on the point of inflection of a plot of risk of stroke/MI. Charlson Index scores were categorized (0, 1 or 2, 2 or 3, and Ն5). The waist-to-hip ratio was dichotomized (Ͼ1 or Յ1). Age was categorized in 5-year increments. Body mass index was categorized as normal (25Ͻ30), underweight (Ͻ25), or overweight (Ն30). Mini-Mental State Examination scores were handled as a binary variable with cut-point of 24 to indicate cognitive impairment. Other continuous variables (such as estimate of glomerular filtration rate, creatinine, systolic blood pressure) were categorized by quartiles. Self-reported health was dichotomized as poor/fair compared with good/excellent. Variables with PϽ0.1 were then included in a multivariate Cox regression model and removed using a backward stepwise process if their significance was not retained. No violations of the Cox proportionality assumption (assessed by scale Schoenfeld residuals during follow-up) were detected. Goodness of fit of the model was evaluated by plotting the observed number of failures in the data and the number predicted in the model by using Martingale residuals. 18 We determined the association between incident stroke/MI and risk factors identified in current risk prediction tools using Cox regression.
To compare this HIMS cardiovascular risk model (HIMS-CVR) with the traditional Framingham model, 19 we initially compared their Harrell C statistics, which measure discrimination ability by indicating the correct ranking of each individual's risk. Harrell C statistic of 0.5 indicates random assignment. We also assessed discrimination of the new model compared to the Framingham risk equation by calculating the integrated discrimination improvement. 20 We then compared calibration of these models by examining how close the predicted risks were to the observed risk for each decile of risk. Finally, we constructed a reclassification table and graph for people with and without stroke/MI and determined the net reclassification improvement. 20 The reclassification table compared participants according to quartiles of risk calculated with the HIMS-CVR and Framingham risk equation.
We then converted the HIMS-CVR to a clinical risk scoring system (HIMS-CVR score [HIMS-CVRS]) by inspecting the B-coefficients associated with each independent predictor of stroke/MI and assigning points values to categories accordingly. 21, 22 We calculated the risk of stroke/MI over the course of 6 years for each increment of the HIMS-CVRS. To do this, we determined the distance of each category from the base category in regression units and set the fixed multiplier to the risk associated with a 6-year BMI indicates body mass index; BP, blood pressure; eGFR, estimate of glomerular filtration rate; HDL, high-density lipoprotein; LDL, low-density lipoprotein. increase in age. 22 We then compared the risk predicted using the model coefficients against the risk predicted using the points from the score system. Finally, we used Poisson regression modeling to build a matrix of rates of stroke/MI comprising the independent predictors of stroke/MI among this population.
Ethics Approval
The Health Department of Western Australia and the Human Research Ethics Committee of the University of Western Australia approved the study. All participants provided written informed consent.
Results

Participants and Rate of Stroke/MI
The cohort comprised 4382 men with a mean age of 75.4 years (SD, 4.2). Baseline clinical characteristics of the cohort are described in Table 1 . Median follow-up was 6 years (interquartile range, 5.2-7.2). During this period, we identified 686 men with incident stroke/MI (overall rate, 2.61; 95% CI, 2.42-2.81 per 100 person-years).
Risk Profile for Incident Stroke/MI in This Cohort
In univariate analyses (Table 1) , age, smoking, comorbidity (both Charlson score and self-reported history of hypertension, diabetes, arthritis, respiratory disease, and depression), central obesity, visual or cognitive impairment, poor selfreported health, estimate of glomerular filtration rate, diastolic hypotension, hyperhomocysteinemia, and elevated CRP were associated with incident stroke/MI. However, in the final parsimonious multivariate model ( 
Utility of Framingham Risk Equation-Based Prediction Tools
The risk of stroke/MI among this population, described according to the risk factors identified in current risk assessment tools, is summarized in Table 3 . Traditional vascular risk factors (diabetes, cholesterol, and blood pressure) were not independently associated with incident stroke/MI in this cohort, with the exception of age (relative risk for age 85 or older, 4.87; 95% CI, 3.00 -7.89) and smoking (relative risk, 1.67; 95% CI, 1.12-2.50).
Assessment of the HIMS-CVR
The HIMS-CVR, comprising age group, diastolic blood pressure 
Development and Assessment of the HIMS-CVRS and Risk Matrix
The HIMS-CVR risk assessment matrix, comprising the significant independent risk factors for stroke/MI, among this cohort of community-dwelling older men is presented in Figure 4 . We translated the HIMS-CVR to an 8-point clinical risk score (HIMS-CVRS) by assigning 1 point to the adverse category of each of the binomial variables (ie, diastolic blood pressure Ͼ70 mm Hg, 0 points; diastolic blood pressure Յ70 mm Hg, 1 point; CRP Ͻ3, 0 points; CRP Ն3, 1 point; homocysteine Ͻ15, 0 points; homocysteine Ն15, 1 point; waist:hip ratio Ͻ1, 0 points; waist:hip ratio Ͼ1, 1 point; good self-reported health, 0 points; poor self-reported health, 1 point) and assigning 0 to 3 points according to the categories of age (ie, age 69 -74, 0 points; 75-79 years, 1 point; 80 -84 years, 2 points; 85 years or older, 3 points). Estimation of risk using the resulting HIMS-CVRS performed similarly to the full HIMS-CVR model (Table 4) with no substantial difference in risk estimates for people in each of the 8 categories of the HIMS-CVRS.
Discussion
Our results show that traditional vascular risk factors are less useful in predicting future stroke/MI among communitydwelling older men than in young men. Instead, the independent predictors of stroke/MI in this population were age, diastolic hypotension, elevated CRP or homocysteine, central obesity, and poor self-perceived health. The risk score we have developed presents a simple and potentially useful approach to improve the assessment of cardiovascular risk among community-dwelling older men.
Diastolic blood pressure was independently associated with stroke/MI in this cohort of older men. Other cohort studies also have observed an association between lower blood pressure and poorer health outcomes. For example, in a sample of older hypertensive men and women older than age 80, of whom 84.5% were receiving antihypertensive medication, systolic blood pressure levels Ͻ140 mm Hg were associated with shorter survival (independent of known predictors of death). 23 Nonetheless, we cannot dismiss entirely the possibility that the association between low diastolic blood pressure and stroke/MI has been confounded by other unmeasured factors, such as previous cardiovascular diseases other than MI. Furthermore, these data should be considered in light of evidence that antihypertensive therapy is beneficial among older people who are hypertensive. 24 Systemic low-grade inflammation, measured using CRP, remained independently associated with incident stroke/MI among this cohort, suggesting an association between clinical or subclinical inflammatory processes and stroke/MI. However, other data are conflicting. For example, genetic deter- minants of CRP levels are not strongly related to risk of coronary heart disease, 25 suggesting that the association between CRP and heart disease may not be causal. Notwithstanding these cautions, our findings are consistent with recent intervention trials establishing that rosuvastatin therapy reduced stroke/MI among participants free from known cardiovascular disease and with CRP levels Ͼ2.0 mmol/ L Ϫ1 . 26 The present data suggest that these results (among relatively young participants; mean age, 66 years) also may be relevant to older men. Our data support the rationale of evaluating the anti-inflammatory hypothesis in patients with cardiovascular disease 27 and suggest that the appropriate management of inflammation may be a valuable strategy to minimize the risk of cardiovascular events among older community-dwelling men.
There are now many data suggesting that homocysteine is an independent risk factor for cardiovascular disease. 28 However, to date, homocysteine-lowering interventions have not been effective in the prevention of cardiovascular diseases, 29 although meta-analysis of the available data suggested that homocysteine-lowering treatment with folate may decrease the risk of stroke by 18%. Thus, some uncertainly persists regarding whether hyperhomocysteinemia is causally related to cardiovascular disease. Notwithstanding these controversies, our results indicate that detection of hyperhomocysteinemia may be useful for cardiovascular risk stratification among community-dwelling older men. Similarly, central obesity is a recognized risk factor for stroke/MI. 30 Our results suggest that waist-to-hip ratio measurement should be incorporated into risk assessments for community-dwelling older men. Self-perceived health is also thought to be an independent predictor of mortality, albeit not consistently. 31 The present data suggest that self-perceived health is an independent predictor of future cardiovascular events among community-dwelling older men.
Limitations and Generalizability
Our stroke/MI incidence data rely on administrative coding of stroke/MI, which was not subjected to external validation. Despite periodic auditing of hospital morbidity data, 32 the administrative coding of diagnoses may be somewhat heterogeneous. The degree of error of diagnostic coding for stroke/MI remains uncertain but is likely to be small. 32, 33 We have tried to guard against overascertainment and underascertainment of stroke/MI diagnoses by choosing International Classification of Diseases codes that optimize detection of stroke/TIA, although some authors have utilized more 34 or less 35 restrictive definitions. In addition, our data are observational, and reverse causality and residual confounding cannot be dismissed. Moreover, because we did not have access to data on treatment, we were unable to take the effects of therapy into account in our models. Generalizability of our data is limited by the inclusion of participants of only 1 gender and the potential for healthy volunteer bias. The potential for volunteer bias is limited to some extent by the population-based nature of the original HIMS cohort and the use of follow-up administrative data (which is not subject to volunteer bias).
Conclusions
Among a cohort of community-dwelling older men, those who experienced a stroke or MI during follow-up, compared with those who remained free from these cardiovascular events, were older, had lower diastolic blood pressure, and had greater waist-to-hip ratio than men who remained free from stroke/MI. In addition to the traditional vascular risk factors of age and smoking, diastolic hypotension, elevated high-sensitivity C-reactive protein, hyperhomocysteinemia, central obesity, and self-reported health status should be considered in the evaluation of cardiovascular risk among community-dwelling older men. If our findings are validated externally, then the risk score we have developed may be useful in the assessment of cardiovascular risk among community-dwelling older men. 。此 外，老年人群中独立的传统危险因素与心血管危险关 联性更小 [6, 7] ，目前的危险预测方法对该人群未必适 用 [8] 。虽然目前不推荐通过评估非传统危险因素来筛 查冠心病风险，但进一步研究的必要性已被公认 
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